HomeRIG2 • FRA
add
Gedeon Richter Ord Shs
Previous close
€24.42
Day range
€23.76 - €24.66
Year range
€21.26 - €25.50
Avg Volume
740.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (HUF) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 203.18B | -9.28% |
Operating expense | 48.08B | -44.99% |
Net income | 36.36B | 235.03% |
Net profit margin | 17.90 | 248.92% |
Earnings per share | — | — |
EBITDA | 90.78B | 110.88% |
Effective tax rate | 10.63% | — |
Balance Sheet
Total assets
Total liabilities
| (HUF) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 87.40B | -20.04% |
Total assets | 1.36T | 0.55% |
Total liabilities | 218.64B | -21.90% |
Total equity | 1.14T | — |
Shares outstanding | 182.77M | — |
Price to book | 0.00 | — |
Return on assets | 15.07% | — |
Return on capital | 16.83% | — |
Cash Flow
Net change in cash
| (HUF) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 36.36B | 235.03% |
Cash from operations | 28.90B | -44.57% |
Cash from investing | -13.16B | 71.65% |
Cash from financing | -32.52B | -715.01% |
Net change in cash | -17.76B | -603.92% |
Free cash flow | 37.13B | -48.47% |
About
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women’s health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
CEO
Founded
1901
Website
Employees
11,603
